NATHAN FOWLER to Cell- and Tissue-Based Therapy
This is a "connection" page, showing publications NATHAN FOWLER has written about Cell- and Tissue-Based Therapy.
Connection Strength
0.317
-
Assessment of Healthcare Resource Utilization and Hospitalization Costs in Patients With Relapsed or Refractory Follicular Lymphoma Undergoing CAR-T Cell Therapy With Tisagenlecleucel: Results From the ELARA Study. Transplant Cell Ther. 2023 01; 29(1):60.e1-60.e4.
Score: 0.169
-
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas. Nat Med. 2020 12; 26(12):1878-1887.
Score: 0.148